Activating mutations in ALK provide a therapeutic target in neuroblastoma.

Source:http://linkedlifedata.com/resource/pubmed/id/18923525

Nature 2008 Oct 16 455 7215 975-8

Download in:

View as

Triples

General Info

PMID
18923525